Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 3 Breast 3 Head & Neck 1 Gynecologic 1 Gastrointestinal 1

Conditions

Oropharyngeal Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 98 pembrolizumab 79 Radiotherapy 49 Carboplatin 41 Magnetic Resonance Spectroscopy 37 toripalimab 34 Radiotherapy, Intensity-Modulated 34 Gemcitabine 29 Docetaxel 28 Cetuximab 28 Specimen Handling 26 Surgical Procedures, Operative 23 Paclitaxel 23 Fluorouracil 22 Radiation 20 Nivolumab 20 Biopsy 18 Drug Therapy 17 Chemoradiotherapy 17 Blood Specimen Collection 17 Capecitabine 15 Surveys and Questionnaires 14 Standard of Care 14 tislelizumab 13 Platinum 13 camrelizumab 12 nimotuzumab 11 Immune Checkpoint Inhibitors 11 130-nm albumin-bound paclitaxel 11 1,2-diaminocyclohexaneplatinum II citrate 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Base Sequence × Head & Neck × Clear all

NCT06642324 2024-12-31

HPV & HNSCC

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Head and Neck Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡